A contract vivarium provides an alternative to building in-house animal facilities or outsourcing to CROs that enables biotech companies to save money and be more confident in their preclinical data. We talked with John Fogarty of Mispro, an official partner of the Stanford Biotechnology Group, to learn more about what a contract vivarium is and what its advantages are. Read more in this blog post written by Logan L.! https://lnkd.in/gRVqcqSY
Stanford Biotechnology Group
Biotechnology Research
Supporting Stanford University students interested in biotech research, business, entrepreneurship, investing, and more.
About us
The Stanford Biotechnology Group (SBG) supports Stanford graduate students, postdocs, and other affiliates from the biosciences, medicine, engineering, business, and law who are interested in biotech research, business, management, entrepreneurship, policy, consulting, and investing. Our goal is to help individuals explore opportunities and build industry connections in biotech by creating avenues for experiential education and career development. We are committed to promoting racial and gender equity in biotech especially as we serve and represent the next generation of biotech leaders.
- Website
-
http://www.stanfordbiotechgroup.com/
External link for Stanford Biotechnology Group
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Type
- Educational
Employees at Stanford Biotechnology Group
Updates
-
Stanford Biotechnology Group reposted this
It was a pleasure hosting Stephanie Wisner, CBO and co-founder of Centivax, for Stanford Biotechnology Group's Women Founders' Series the other evening! Stephanie gave a talk highlighting the importance of of building biotech companies with key milestones in mind, followed by a Q&A where she shared insights from her career and advice for students. A big thank you to Stephanie for joining us! Additionally, I would also like to to extend my gratitude to Alan S.H. Tung and Jack Shumway for their help coordinating this event.
-
We had an incredible time at our recent TechBio Meetup event! A huge thanks to our amazing speakers, Berton Earnshaw and Eric Nguyen, for their insightful and inspiring talks and to Valence Labs for co-hosting and helping make this event a great success! We were thrilled to see a full house of engaged and enthusiastic attendees. Finally, we would also like to highlight Kexin Huang, Shriram Chennakesavalu, and Jonathan Hsu for organizing this event!
-
Our presidents, Michelle Tai and Sarah Jones had the opportunity to meet some influential leaders and innovators at a retreat in Boston hosted by Pillar VC last week.
Last week, I was fortunate enough to participate in a two-day retreat hosted by the team at Pillar VC with the other leaders of our country-wide Biotech Coalition. As it happened, the presidents and leaders of Stanford Biotechnology Group, GSAS Harvard Biotech Club, Dartmouth Biotech Club, Yale Biotech Club, and BIOTECH XYZ who started the coalition this year were all women. Thanks to Madelyn Heart and Grace Barrett, we were able to all meet in-person for the first time and get to know leaders within the biotech ecosystem. Thank you to Shi Yin Foo (Arvada Tx), Ivana Muncie-Vasic (Vitra Labs), Luciano Bueno (GALY), Traci Haddock (Asimov), Vanessa Barth (Eli Lilly and Company), Anna Marie Wagner (Ginkgo Bioworks, Inc.), Thomas de Vlaam, and Tony Kulesa for taking the time to share your experiences and helping to inspire the next generation of women in biotech!
-
This event has been rescheduled to Thursday May 16th at 6pm, and will now be featuring talks from Berton Earnshaw and Brian Hie! Please RSVP at https://lu.ma/e040ofej!
The Stanford Biotech Group, in collaboration with Valence Labs, is excited to announce our upcoming TechBio meetup! This event will feature a talk from Professor Brian Hie on using Large Language Models to model and investigate biological systems from the molecular to genome scale. Following this talk, we will have a happy hour, which will be a great opportunity to chat with fellow TechBio enthusiasts about current problems in the space. Join us in person on Monday April 22nd at 6pm for an evening of great conversation, food and drinks. Please RSVP at lu.ma/techbio!
-
Ventyx, a once-promising biotech, saw its market value drop from $2.4 billion to $140 million due to disappointing data on ulcerative colitis and plaque psoriasis candidates, prompting the discontinuation of VTX958 in two indications due to market competition. Jason Akram discusses the rise and fall of Ventyx's primary candidate in our latest Biotech Insights Blog! https://lnkd.in/gveG2_Rf
Analyzing the Rise and Fall of Ventyx’s Primary Candidate — Stanford Biotechnology Group
stanfordbiotechgroup.com
-
Interested in learning more about a career transition from PhD scientist to patent lawyer? We interviewed Julia Minitti and Joy Wang who work at Wilson Sonsini Goodrich & Rosati, one of the leading firms for helping biotech companies secure IP through the U.S. patent system. Read more in our most recent blog post written by Logan L.! https://lnkd.in/g4BARJ8y
From PhD to Patent Law: An Interview with Wilson Sonsini — Stanford Biotechnology Group
stanfordbiotechgroup.com
-
Stanford Biotechnology Group reposted this
We're so excited to announce the inaugural machine learning for drug discovery summer school in partnership with IVADO, Valence Labs, and Mila - Quebec Artificial Intelligence Institute! 🏫 What: The program includes 20 hours of lectures from professors like Yoshua Bengio, Anne Carpenter, Pratyush Tiwary, Bharath Ramsundar and more, 8 hours of labs, followed by a 2-day hackathon. 📍Where: Hosted Mila - Quebec Artificial Intelligence Institute 📅 When: June 12th - 21st As part of the programming, we’ll also be hosting the 2024 Molecular Machine Learning Conference (#MoML2024) on June 19th. Register for the summer school and learn more about the program here: https://portal.ml4dd.com/
Machine Learning for Drug Discovery Summer School
portal.ml4dd.com
-
The Stanford Biotech Group, in collaboration with Valence Labs, is excited to announce our upcoming TechBio meetup! This event will feature a talk from Professor Brian Hie on using Large Language Models to model and investigate biological systems from the molecular to genome scale. Following this talk, we will have a happy hour, which will be a great opportunity to chat with fellow TechBio enthusiasts about current problems in the space. Join us in person on Monday April 22nd at 6pm for an evening of great conversation, food and drinks. Please RSVP at lu.ma/techbio!
-
We recently hosted Dr. Leah Makley, COO at MBC BioLabs as part of our annual Women Founders Series. Leah's story of building and selling ViewPoint Therapeutics from her PhD project was truly insightful and full of practical advice. We are grateful for her time and wisdom in sharing her career journey. We appreciate the great work by Rebecca Rodell in organizing this event for the Stanford Biotechnology Group!